Bellevue Asset Management AG current holdings: USA Stocks
Bellevue Asset Management AG reported $0.41 billion in share positions in stocks (listed in the US), 68 positions, in its Form 13F for the quarter ended 2015-12-31; the largest are BIIB, GILD, AMGN.
- BIIB: Country of operation United States; Class COM; Shares 84,030; Value $25,743,000.
- GILD: Country of operation United States; Class COM; Shares 240,120; Value $24,298,000.
- AMGN: Country of operation United States; Class COM; Shares 123,000; Value $19,967,000.
- REGN: Country of operation United States; Class COM; Shares 36,400; Value $19,760,000.
Form 13F-HR as filed (SEC CIK 1642343): quarter ended 2015-12-31, filed 2016-02-12. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Performance is each holding's price change from its close on the 2015-12-31 quarter end to its latest retained close (2026-09-29, or the date shown for a stock that stopped trading). Price only; dividends are not included. A stock that split in the period is restated by the split ratio in its own Form 8-K; a dash marks a holding with no retained closes.
| Stock | Country of operation | Class | Shares | Value | % of listed | Quarter end | Filed | Performance |
|---|
BIIB
Biogen Inc. | United States | COM | 84,030 | $25,743,000 | 6.04% | 2015-12-31 | 2016-02-12 | -25.88% |
|---|
GILD
Gilead Sciences, Inc. | United States | COM | 240,120 | $24,298,000 | 5.70% | 2015-12-31 | 2016-02-12 | +49.50% |
|---|
AMGN
Amgen Inc. | United States | COM | 123,000 | $19,967,000 | 4.68% | 2015-12-31 | 2016-02-12 | +160.97% |
|---|
REGN
Regeneron Pharmaceuticals, Inc. | United States | COM | 36,400 | $19,760,000 | 4.64% | 2015-12-31 | 2016-02-12 | +38.25% |
|---|
ILMN
Illumina, Inc. | United States | COM | 91,425 | $17,549,000 | 4.12% | 2015-12-31 | 2016-02-12 | +45.67% |
|---|
ABT
Abbott Laboratories | United States | COM | 381,500 | $17,133,000 | 4.02% | 2015-12-31 | 2016-02-12 | +124.78% |
|---|
BDX
Becton, Dickinson and Company | United States | COM | 105,075 | $16,191,000 | 3.80% | 2015-12-31 | 2016-02-12 | +53.96% |
|---|
CAH
Cardinal Health, Inc. | United States | COM | 171,480 | $15,308,000 | 3.59% | 2015-12-31 | 2016-02-12 | +150.82% |
|---|
UNH
UnitedHealth Group Incorporated | United States | COM | 120,000 | $14,117,000 | 3.31% | 2015-12-31 | 2016-02-12 | +218.72% |
|---|
SYK
Stryker Corporation | United States | COM | 140,700 | $13,077,000 | 3.07% | 2015-12-31 | 2016-02-12 | +199.95% |
|---|
ZBH
Zimmer Holdings, Inc. | United States | COM | 95,500 | $9,797,000 | 2.30% | 2015-12-31 | 2016-02-12 | -8.29% |
|---|
CVS
CVS Health Corporation | United States | COM | 96,200 | $9,405,000 | 2.21% | 2015-12-31 | 2016-02-12 | -10.91% |
|---|
LGND
Ligand Pharmaceuticals Incorporated | United States | COM NEW | 81,640 | $8,851,000 | 2.08% | 2015-12-31 | 2016-02-12 | +358.84% |
|---|
INCY
Incyte Corporation | United States | COM | 79,000 | $8,568,000 | 2.01% | 2015-12-31 | 2016-02-12 | +13.60% |
|---|
IONS
Ionis Pharmaceuticals Inc. | United States | COM | 138,000 | $8,546,000 | 2.00% | 2015-12-31 | 2016-02-12 | -25.90% |
|---|
BSX
Boston Scientific Corporation | United States | COM | 460,000 | $8,482,000 | 1.99% | 2015-12-31 | 2016-02-12 | +137.96% |
|---|
MCK
McKesson Corporation | United States | COM | 43,000 | $8,481,000 | 1.99% | 2015-12-31 | 2016-02-12 | +338.48% |
|---|
JAZZ
Jazz Pharmaceuticals Public Limited Company | | SHS USD | 60,000 | $8,434,000 | 1.98% | 2015-12-31 | 2016-02-12 | +65.30% |
|---|
VRTX
Vertex Pharmaceuticals Incorporated | United States | COM | 67,000 | $8,431,000 | 1.98% | 2015-12-31 | 2016-02-12 | +318.60% |
|---|
CNC
Centene Corporation | United States | COM | 105,630 | $6,952,000 | 1.63% | 2015-12-31 | 2016-02-12 | — split 2025-07-02, ratio not on file |
|---|
BMRN
BioMarin Pharmaceutical Inc. | United States | COM | 65,000 | $6,809,000 | 1.60% | 2015-12-31 | 2016-02-12 | -42.85% |
|---|
COR
AmerisourceBergen Corporation | United States | COM | 64,000 | $6,637,000 | 1.56% | 2015-12-31 | 2016-02-12 | +196.60% |
|---|
PRGO
Perrigo Company plc | Ireland | SHS | 44,000 | $6,367,000 | 1.49% | 2015-12-31 | 2016-02-12 | -89.63% |
|---|
ISRG
Intuitive Surgical, Inc. | United States | COM NEW | 11,550 | $6,308,000 | 1.48% | 2015-12-31 | 2016-02-12 | +579.27% |
|---|
CHRS
Coherus BioSciences, Inc | United States | COM | 257,000 | $5,901,000 | 1.38% | 2015-12-31 | 2016-02-12 | -94.86% |
|---|
HALO
Halozyme Therapeutics, Inc. | United States | COM | 318,000 | $5,511,000 | 1.29% | 2015-12-31 | 2016-02-12 | +543.74% |
|---|
EW
Edwards Lifesciences Corporation | United States | COM | 69,000 | $5,450,000 | 1.28% | 2015-12-31 | 2016-02-12 | +234.52% |
|---|
HUM
Humana, Inc. | United States | COM | 30,000 | $5,355,000 | 1.26% | 2015-12-31 | 2016-02-12 | +116.72% |
|---|
ALKS
Alkermes Public Limited Company | | SHS | 65,500 | $5,199,000 | 1.22% | 2015-12-31 | 2016-02-12 | — split 2016-01-21, ratio not on file |
|---|
JNJ
Johnson & Johnson | United States | COM | 50,000 | $5,136,000 | 1.20% | 2015-12-31 | 2016-02-12 | +160.48% |
|---|
EGBN
EAGLE PHARMACEUTICALS INC | United States | COM | 55,000 | $4,877,000 | 1.14% | 2015-12-31 | 2016-02-12 | -44.60% |
|---|
SUPN
Supernus Pharmaceuticals, Inc. | United States | COM | 355,000 | $4,771,000 | 1.12% | 2015-12-31 | 2016-02-12 | +227.16% |
|---|
CYH
Community Health Systems, Inc. | United States | COM | 174,440 | $4,628,000 | 1.09% | 2015-12-31 | 2016-02-12 | — split 2016-10-27, ratio not on file |
|---|
BAX
Baxter International Inc. | United States | COM | 110,000 | $4,197,000 | 0.98% | 2015-12-31 | 2016-02-12 | -38.45% |
|---|
ELV
Anthem, Inc. | United States | COM | 30,000 | $4,183,000 | 0.98% | 2015-12-31 | 2016-02-12 | +181.65% |
|---|
BMY
Bristol-Myers Squibb Company | United States | COM | 60,000 | $4,127,000 | 0.97% | 2015-12-31 | 2016-02-12 | -8.62% |
|---|
HCA
HCA Holdings, Inc. | United States | COM | 60,000 | $4,058,000 | 0.95% | 2015-12-31 | 2016-02-12 | +538.22% |
|---|
NBIX
Neurocrine Biosciences, Inc. | United States | COM | 65,000 | $3,677,000 | 0.86% | 2015-12-31 | 2016-02-12 | +144.56% |
|---|
PFE
Pfizer Inc. | United States | COM | 110,000 | $3,551,000 | 0.83% | 2015-12-31 | 2016-02-12 | -6.22% |
|---|
AGIO
Agios Pharmaceuticals, Inc. | United States | COM | 54,000 | $3,506,000 | 0.82% | 2015-12-31 | 2016-02-12 | — split 2025-11-19, ratio not on file |
|---|
MRK
Merck & Co., Inc. | United States | COM | 60,000 | $3,169,000 | 0.74% | 2015-12-31 | 2016-02-12 | +196.19% |
|---|
HOLX
Hologic, Inc. | United States | COM | 81,000 | $3,134,000 | 0.74% | 2015-12-31 | 2016-02-12 | |
|---|
MASI
Masimo Corporation | United States | COM | 75,000 | $3,113,000 | 0.73% | 2015-12-31 | 2016-02-12 | |
|---|
LLY
Lilly Eli & Co. | United States | COM | 35,000 | $2,949,000 | 0.69% | 2015-12-31 | 2016-02-12 | +1305.92% |
|---|
TMO
Thermo Fisher Scientific Inc. | United States | COM | 20,000 | $2,837,000 | 0.67% | 2015-12-31 | 2016-02-12 | +379.10% |
|---|
MGNX
Macrogenics, Inc. | United States | COM | 83,000 | $2,571,000 | 0.60% | 2015-12-31 | 2016-02-12 | — split 2019-02-06, ratio not on file |
|---|
GMED
Globus Medical, Inc. | United States | CL A | 87,700 | $2,440,000 | 0.57% | 2015-12-31 | 2016-02-12 | +172.07% |
|---|
TFX
Teleflex Incorporated | United States | COM | 18,557 | $2,439,000 | 0.57% | 2015-12-31 | 2016-02-12 | -3.90% |
|---|
HCSG
Healthcare Services Group Inc. | United States | COM | 65,000 | $2,267,000 | 0.53% | 2015-12-31 | 2016-02-12 | -40.06% |
|---|
ALNY
Alnylam Pharmaceuticals Inc. | United States | COM | 24,000 | $2,259,000 | 0.53% | 2015-12-31 | 2016-02-12 | — split 2016-10-06, ratio not on file |
|---|
PRTA
Prothena Corporation plc | Ireland | SHS | 31,000 | $2,111,000 | 0.50% | 2015-12-31 | 2016-02-12 | — split 2018-04-23, ratio not on file |
|---|
PTCT
PTC Therapeutics Inc. | United States | COM | 55,000 | $1,782,000 | 0.42% | 2015-12-31 | 2016-02-12 | — split 2016-02-23, ratio not on file |
|---|
ACAD
Acadia Pharmaceuticals, Inc. | United States | COM | 45,000 | $1,604,000 | 0.38% | 2015-12-31 | 2016-02-12 | — split 2021-03-09, ratio not on file |
|---|
UTHR
United Therapeutics Corporation | United States | COM | 9,300 | $1,456,000 | 0.34% | 2015-12-31 | 2016-02-12 | +207.43% |
|---|
DVA
Davita Healthcare Partners, Inc. | United States | COM | 20,000 | $1,394,000 | 0.33% | 2015-12-31 | 2016-02-12 | +151.31% |
|---|
INFIQ
Infinity Pharmaceuticals, Inc. | United States | COM | 160,000 | $1,256,000 | 0.29% | 2015-12-31 | 2016-02-12 | |
|---|
ANGO
AngioDynamics, Inc. | United States | COM | 100,000 | $1,214,000 | 0.28% | 2015-12-31 | 2016-02-12 | +28.50% |
|---|
RARE
Ultragenyx Pharmaceuticals Inc. | United States | COM | 10,000 | $1,122,000 | 0.26% | 2015-12-31 | 2016-02-12 | — split 2025-12-29, ratio not on file |
|---|
EXEL
Exelixis, Inc. | United States | COM | 170,000 | $959,000 | 0.22% | 2015-12-31 | 2016-02-12 | +939.89% |
|---|
ESPR
Esperion Therapeutics Inc. | United States | COM | 40,000 | $890,000 | 0.21% | 2015-12-31 | 2016-02-12 | |
|---|
ABBV
Abbvie Inc. | United States | COM | 15,000 | $889,000 | 0.21% | 2015-12-31 | 2016-02-12 | +344.45% |
|---|
RMD
ResMed Inc. | United States | COM | 15,000 | $805,000 | 0.19% | 2015-12-31 | 2016-02-12 | +315.03% |
|---|
PODD
Insulet Corporation | United States | COM | 21,000 | $794,000 | 0.19% | 2015-12-31 | 2016-02-12 | +251.34% |
|---|
MYGN
Myriad Genetics, Inc. | United States | COM | 14,000 | $604,000 | 0.14% | 2015-12-31 | 2016-02-12 | — split 2019-08-14, ratio not on file |
|---|
ABUS
Arbutus Biopharm Corporation | | COM | 125,000 | $556,000 | 0.13% | 2015-12-31 | 2016-02-12 | — split 2020-03-27, ratio not on file |
|---|
THC
Tenet Healthcare Corporation | United States | COM NEW | 10,000 | $303,000 | 0.07% | 2015-12-31 | 2016-02-12 | +750.17% |
|---|
GERN
Geron Corporation | United States | COM | 45,000 | $218,000 | 0.05% | 2015-12-31 | 2016-02-12 | — split 2018-09-27, ratio not on file |
|---|
TBPH
Theravance Biopharma, Inc. | | COM | 11,428 | $187,000 | 0.04% | 2015-12-31 | 2016-02-12 | +3.90% |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |